Can there be anything even remotely close to a disease free world? That’s the question medical science and the general public at large has been asking for the last 50 years. It’s not a question easily answered but developers of Curecoin (CURE) believe ardently that a disease free world is possible and that it is Curecoin that will do it. It’s a bold promise and many are now wondering how feasible it is.
To understand the possibilities we first have to understand how Curecoin, by its foundations and structure, will potentially make this possible. Like most cryptocurrencies, CURE can be mined, that is to say, people with a personal computer and enough computing power can plug into the blockchain and mine coins for personal gains. Curecoin takes this principle one level higher by focusing not so much on the incentive to mine coins for a profit, but towards the contribution to science. CURE calls its process for plugging into the mining process “folding,” a term that grew out of previous research started by a one Dr Pande of Stanford University. Dr Pande created the Folding@home project, an initiative that is geared towards having regular people or have-a-go-scientists, dedicate their computing resources to research into diseases.
CURE is therefore a natural outgrowth of the fold@home project and it has started to attract the attention of the public in a big way. It’s not difficult to see why. Diseases like cancer, Alzheimer’s and Ebola have sharpened fears significantly over the last three decades. Today more than 8M people die from cancer globally; that figure is set to climb to 22M in the next two decades and medical science has so far seemed powerless to stop its growth and devastation. The answer is of course research, but that research is expensive and it is this hurdle that CURE is taking bold steps to fill.
The uptake of the CURE project has been very promising and encouraging. So far, over $25,000 of mined coins has been poured into the research side of the project; making the token one of the most humanitarian-centered cryptocurrencies currently on the blockchain to date.
In terms of its efficacy, CURE has also been breaking records since it went live. The metric of folds on the fold@home project is of course folds, and CURE managed to set a record number of folds on the project protein folding simulation Distributed Computing Network (DCN). This was a fantastic start because it meant CURE had proof of work right off the bat, something not many digital currencies and their attendant platform have managed to claim over the last 5 years of new launches.
The big question of course is how long Curecoin can go before it starts attracting the attention of the biggest names in medical science. The obvious answer is that CURE has already started to do that in a small way so it’s just a matter of time before all the bigger players come on board. Already CURE has landed a few notable partners, including Capsule Corp. Microtech. Other partners on the blockchain side include CoinDesk, CoinPayments and EOBOT.
Trading for CURE has been relatively steady with the coin currently quoted at $0.28 a coin on the popular trdaing platform coinmarketcap.com. Market cap for the digital token is around $6.7M and circulating supply is around 23.8M coins. Trading wise, the real story has been the big spike which came around January 10. CURE surprised many traders and investors with launched itself to a high of $1.10, the highest level it’s reached ever. Investors and traders no doubt will be looking for a repetition of this breakout but underneath it all, CURE looks poised to do something big for scientific research.